Belgium· BE-AMP-SAM527733-00
Fasenra 30 mg
A benralizumab product containing benralizumab, registered in Belgium by AstraZeneca. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Benralizumab is registered in 16 of 19 countries.
Countries holding a registration under ATC R03DX10 (benralizumab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Benralizumab · ATC R03DX10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Benralizumab
- Manufacturer
- AstraZeneca
- Country
- Belgium (BE)
- ATC code
- R03DX10
- ATC class
- Benralizumab
- Defined daily dose
- 0.54 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
2 priced- be_apb3678448EUR 2422.49
- be_apb4169637EUR 2422.49
- be_apb7727993
- be_apb7723125
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Benralizumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayFasenraAstraZeneca AB (2)
- CzechiaFASENRAAstraZeneca AB, Södertälje
- SpainFASENRA 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAAstrazeneca Ab
- United KingdomFasenra 30mg/1ml solution for injection pre-filled pensAstraZeneca UK Ltd
- IcelandFasenraAstraZeneca AB
- SwedenFasenra 30 mg Injektionsvätska, lösning i förfylld injektionspennaAstraZeneca AB
- SwitzerlandFasenra
- FinlandFasenraAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Fasenra
- Liechtenstein · Fasenra
- Norway · Fasenra
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/89235ca7-129b-4af6-879d-33874a4e528d GET /v1/drugs/89235ca7-129b-4af6-879d-33874a4e528d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled syringe",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Fasenra 30 mg",
"name_fr": "Fasenra 30 mg",
"name_nl": "Fasenra 30 mg",
"amp_code": "SAM527733-00",
"strengths": [
"30.0000"
],
"pack_count": 4,
"substances": [
"Benralizumab",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Benralizumab",
"authorisation_numbers": [
"EU/1/17/1252/001"
]
}See everything about benralizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.